Journal
Frontiers in Pharmacology
Publication Date
1-1-2020
Volume
11
First Page
604885
Document Type
Open Access Publication
DOI
10.3389/fphar.2020.604885
Rights and Permissions
Scala R, Maqoud F, Zizzo N, Mele A, Camerino GM, Zito FA, Ranieri G, McClenaghan C, Harter TM, Nichols CG and Tricarico D (2020) Pathophysiological Consequences of KATP Channel Overactivity and Pharmacological Response to Glibenclamide in Skeletal Muscle of a Murine Model of Cantù Syndrome. Front. Pharmacol. 11:604885. doi: 10.3389/fphar.2020.604885 © 2020 Scala, Maqoud, Zizzo, Antonietta, Camerino, Zito, Ranieri, Mcclenaghan, Harter, Nichols and Tricarico. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Scala, Rosa; Maqoud, Fatima; Zizzo, Nicola; Mele, Antonietta; Camerino, Giulia Maria; Zito, Francesco Alfredo; Ranieri, Girolamo; McClenaghan, Conor; Harter, Theresa M; Nichols, Colin G; and Tricarico, Domenico, "Pathophysiological consequences of KATP channel overactivity and pharmacological response to glibenclamide in skeletal muscle of a murine model of Cantù syndrome." Frontiers in Pharmacology. 11, 604885 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9994
